HETEROCYCLIC INHIBITORS OF CDC-LIKE KINASES

The present invention relates to compounds of formula (I). The compounds may be used to inhibit Cdc-Like Kinases, and thereby treat cancer, inflammatory disease, neurodegenerative disease, infection, tendinopathy, Duchenne muscular dystrophy or osteoarthritis. La présente invention concerne des comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PRYDE, David Cameron, GHOSH, Rajib, DEBNATH, Sabyasachi, YADAV, Dharmendra B, SHRIVASTAVA, Ritesh Kumar, BANERJEE, Monali, MIDDYA, Sandip Kumar, BASU, Sourav, SURYA, Arjun
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to compounds of formula (I). The compounds may be used to inhibit Cdc-Like Kinases, and thereby treat cancer, inflammatory disease, neurodegenerative disease, infection, tendinopathy, Duchenne muscular dystrophy or osteoarthritis. La présente invention concerne des composés de formule (I). Les composés peuvent être utilisés pour inhiber des kinases de type Cdc, et ainsi traiter un cancer, une maladie inflammatoire, une maladie neurodégénérative, une infection, une tendinopathie, une dystrophie musculaire de Duchenne ou une arthrose.